ライフサイエンスコーパス: Newcastle disease virus

1 ells infected with a heterologous RNA virus (Newcastle disease virus).

2 ing a control or fusion protein derived from Newcastle disease virus.

3 idase (HN) glycoprotein of the paramyxovirus Newcastle disease virus.

4 onse to HSV-1, but not to Sendai virus or to Newcastle disease virus.

5 d to rescue replication of the IFN-sensitive Newcastle disease virus.

6 nts similar to the one for cells infected by Newcastle disease virus.

7 omography to show that the matrix protein of Newcastle disease virus, a paramyxovirus and relative of

8 mutation is demonstrated in the F protein of Newcastle disease virus, a paramyxovirus of a different

9 nduced by all IL-33-inducing agonists except Newcastle disease virus, a RIG-I agonist that induced ex

10 We found that matrix proteins purified from Newcastle disease virus adsorb on a phospholipid bilayer

11 d RNA viruses that have dsRNA intermediates, Newcastle disease virus and Sendai virus, and a DNA viru

12 Newcastle disease virus and vesicular stomatitis virus (

13 In this study, we found Newcastle disease virus and vesicular stomatitis virus r

14 from non-target viruses such as H6N2, H9N2, Newcastle disease virus, and infectious bronchitis virus

15 efficacy: vaccinia, measles, mumps, viruses, Newcastle disease virus, and reovirus.

16 ense RNA viruses (influenza viruses A and B, Newcastle disease virus, and vesicular stomatitis virus)

17 simplex virus type-1 (HSV-1), Sendai virus, Newcastle disease virus, and vesicular stomatitis virus.

18 W proteins) were expressed from recombinant Newcastle disease viruses, and the responses of infected

19 Newcastle disease virus assembles in plasma membrane dom

20 NDV-HXP-S is a recombinant Newcastle disease virus-based vaccine against SARS-CoV-2

21 PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xeno

22 packaging revealed a majority of infectious Newcastle disease viruses contain one functional genome.

23 Here, we present a recombinant Newcastle disease virus expressing a North American line

24 ns for the ability to rescue the growth of a Newcastle disease virus expressing green fluorescent pro

25 mutational analysis of the HR1 domain of the Newcastle disease virus fusion protein, focusing on the

26 This model uses the Newcastle disease virus hemagglutinin-neuraminidase prot

27 on of HN of parainfluenza virus 5 (PIV5) and Newcastle disease virus HN abolishes cell-cell fusion, w

28 Here, we report the structure of the Newcastle disease virus HN ectodomain, revealing dimers

29 embrane fusion, we characterized a series of Newcastle disease virus HN proteins whose surface residu

30 ith functionally active "headless" mumps and Newcastle disease virus HN proteins, provide insights in

31 Mutations of the Newcastle disease virus HN stalk region have been shown

32 e second receptor-binding site identified in Newcastle disease virus HN.

33 ose to the second binding site identified in Newcastle disease virus HN.

34 paramyxoviruses measles virus, mumps virus, Newcastle disease virus, human parainfluenza virus 3, an

35 d receptor binding site of the paramyxovirus Newcastle disease virus in its function and its relation

36 the growth of a highly IFN-sensitive virus (Newcastle disease virus) in the presence of IFN, suggest

37 ways associated with immune response to NDV (Newcastle disease virus) in the trachea, an essential or

38 nd tumor necrosis factor alpha (TNFalpha) in Newcastle disease virus-infected Irf5(-)(/)(-) mice.

39 not type I interferon gene transcription in Newcastle disease virus-infected peritoneal macrophages.

40 Quantitative RT-PCR analysis on Newcastle disease virus-infected primary DCs from 130 in

41 le NF-kappaB activity, both Sendai virus and Newcastle disease virus infection led to robust IFN-beta

42 N expression in response to Sendai virus and Newcastle disease virus infection.

43 ther stimuli, such as lipopolysaccharide and Newcastle disease virus infection.

44 on of interferon beta mRNA 27-fold following Newcastle disease virus infection.

45 As with any other RNA virus, Newcastle disease virus is expected to evolve naturally;

46 opathological characterization of a virulent Newcastle disease virus isolate (NDV-Peru/08) obtained f

47 Newcastle disease viruses isolated from Hong Kong live b

48 ed to mimic sites that are found in virulent Newcastle disease virus isolates and to contain 4 or 5 b

49 Eight Newcastle disease virus isolates from Pakistan were sequ

50 Fifteen Newcastle disease virus isolates were recovered only fro

51 AVX/COVID-12 vaccine using a cost-effective Newcastle disease virus LaSota platform to express a sta

52 DCs) by negative-strand RNA viruses, such as Newcastle disease virus, leads to the induction of the I

53 Here we use Newcastle Disease Virus-like particle (NDV-VLP) platform

54 Low-virulence Newcastle disease viruses (loNDV) are frequently recover

55 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus mediates attachment to sialic ac

56 We previously proved that the oncolytic Newcastle disease virus (NDV) activated ferroptosis to k

57 the response of DCs to virus infection with Newcastle disease virus (NDV) after a 24-hour E2 treatme

58 VLP is composed of the NP and M proteins of Newcastle disease virus (NDV) and a chimeric protein con

59 MuRantes mRNA expression is induced by Newcastle disease virus (NDV) and LPS in the RAW 264.7 m

60 The fusion (F) proteins of Newcastle disease virus (NDV) and Nipah virus (NiV) are

61 he level of IFN-beta protein induced by both Newcastle disease virus (NDV) and Sendai virus infection

62 In this study, we have evaluated Newcastle disease virus (NDV) as a vaccine vector for no

63 c and mucosal immune responses by the use of Newcastle disease virus (NDV) as a vaccine vector.

64 linical development of a mesogenic strain of Newcastle disease virus (NDV) as an oncolytic agent for

65 Newcastle disease virus (NDV) belongs to serotype 1 of t

66 Newcastle disease virus (NDV) can cause severe disease i

67 Virulent strains of Newcastle disease virus (NDV) cause Newcastle disease (N

68 Virus-like particles (VLPs) built on the Newcastle disease virus (NDV) core proteins, NP and M, a

69 h virus-like particles (VLPs) containing the Newcastle disease virus (NDV) core proteins, NP and M, a

70 several paramyxoviruses.IMPORTANCE Oncolytic Newcastle disease virus (NDV) could establish persistent

71 Newcastle disease virus (NDV) edits its P gene by insert

72 Newcastle disease virus (NDV) entry into host cells is m

73 Newcastle disease virus (NDV) expressing HIV-1 BaL gp160

74 respiratory tract based on recombinant avian Newcastle disease virus (NDV) expressing the hemagglutin

75 such a stimulus, we generated a recombinant Newcastle disease virus (NDV) expressing the MV hemagglu

76 iotin-labeled peptides with sequences of the Newcastle disease virus (NDV) F protein heptad repeat 2

77 and 289 in the structure and function of the Newcastle disease virus (NDV) F protein was explored by

78 the basis of the coordinates of the related Newcastle disease virus (NDV) F protein, Valine-94, a de

79 ith those of the parainfluenza virus SV5 and Newcastle disease virus (NDV) F proteins, the structures

80 has been demonstrated that the V protein of Newcastle disease virus (NDV) functions as an alpha/beta

81 The effects of Newcastle disease virus (NDV) fusion (F) glycoprotein cl

82 The sequence and structure of the Newcastle disease virus (NDV) fusion (F) protein are con

83 Newcastle disease virus (NDV) fusion (F) protein directs

84 It has been shown that the L289A-mutated Newcastle disease virus (NDV) fusion (F) protein gains t

85 The synthesis of the Newcastle disease virus (NDV) fusion (F) protein in a ce

86 equences in the transmembrane (TM) domain of Newcastle disease virus (NDV) fusion (F) protein in the

87 The role of N-linked glycosylation of the Newcastle disease virus (NDV) fusion (F) protein in vira

88 To explore the association of the Newcastle disease virus (NDV) fusion (F) protein with ch

89 The Newcastle disease virus (NDV) fusion protein (F) mediate

90 y viral fusion proteins, the sequence of the Newcastle disease virus (NDV) fusion protein has several

91 uman parainfluenza virus type 3 (HPIV-3) and Newcastle disease virus (NDV) have been previously evalu

92 Naturally occurring strains of Newcastle disease virus (NDV) have shown oncolytic thera

93 The Newcastle disease virus (NDV) hemagglutinin-neuraminidas

94 onstrate that the F-interactive sites on the Newcastle disease virus (NDV) hemagglutinin-neuraminidas

95 To explore the relationships between Newcastle disease virus (NDV) HN and F protein interacti

96 Newcastle disease virus (NDV) HN and HPIV3 HN respond di

97 The stalk region of the Newcastle disease virus (NDV) HN protein has been implic

98 alysis of the three-dimensional structure of Newcastle disease virus (NDV) HN protein revealed the pr

99 e residues in the functional activity of the Newcastle disease virus (NDV) HN protein.

100 tion, mutations in a conserved domain in the Newcastle disease virus (NDV) HN stalk result in a sharp

101 porated into progeny Sendai virions, whereas Newcastle disease virus (NDV) HN was not.

102 e second receptor-binding site identified in Newcastle disease virus (NDV) HN.

103 morbidity-mortality event involving virulent Newcastle disease virus (NDV) in wild double-crested cor

104 Upon newcastle disease virus (NDV) infection, bone marrow-der

105 We show that, in addition to Newcastle disease virus (NDV) infection, vesicular stoma

106 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a multifunctional prote

107 Newcastle disease virus (NDV) is a negative-sense RNA vi

108 Newcastle disease virus (NDV) is a negative-strand RNA v

109 Newcastle disease virus (NDV) is a threat to the global

110 Newcastle disease virus (NDV) is an attractive candidate

111 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is an important determinan

112 Newcastle disease virus (NDV) is an oncolytic virus bein

113 ug-resistant cancers.IMPORTANCEThe oncolytic Newcastle disease virus (NDV) is being developed for use

114 The characteristics of three virulent Newcastle disease virus (NDV) isolates from this outbrea

115 However, VLPs composed of the Newcastle disease virus (NDV) nucleocapsid and membrane

116 The disease is caused by Newcastle disease virus (NDV) or avian paramyxovirus typ

117 A Newcastle disease virus (NDV) outbreak in chickens was r

118 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) plays a crucial role in th

119 We generated a recombinant Newcastle disease virus (NDV) possessing a two-segmented

120 In the present study, we generated Newcastle disease virus (NDV) recombinants expressing gl

121 In the present study, we generated Newcastle disease virus (NDV) recombinants, based on the

122 tinin-neuraminidase (HN) cytoplasmic tail in Newcastle disease virus (NDV) replication and pathogenic

123 Newcastle disease virus (NDV) replication depends on the

124 The promotion of membrane fusion by Newcastle disease virus (NDV) requires an interaction be

125 Ps) released from avian cells expressing the Newcastle disease virus (NDV) strain AV proteins NP, M,

126 The complete genome sequence of an African Newcastle disease virus (NDV) strain isolated from a chi

127 Newcastle disease virus (NDV) strains are classified as

128 onomic losses, but little is known about the Newcastle disease virus (NDV) strains circulating in Afr

129 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

130 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

131 Eight highly virulent Newcastle disease virus (NDV) strains were isolated from

132 ystallographic structure of an HN dimer from Newcastle disease virus (NDV) suggests that a single sit

133 eloped a COVID-19 vaccine candidate based on Newcastle disease virus (NDV) that can be manufactured a

134 We have generated a recombinant Newcastle disease virus (NDV) that expresses the green f

135 combination of gold nanoparticles (GNPs) and Newcastle disease virus (NDV) to enhance the antitumor e

136 A complete cDNA clone of the Newcastle disease virus (NDV) vaccine strain Hitchner B1

137 Thermostable Newcastle disease virus (NDV) vaccines have been used wi

138 he present study, we generated a recombinant Newcastle disease virus (NDV) vectoring the fusion (F) p

139 Newcastle disease virus (NDV) was isolated from an outbr

140 the membrane cytoskeleton in the assembly of Newcastle disease virus (NDV) were investigated.

141 ression of the fusion glycoprotein of RSV by Newcastle disease virus (NDV) would stimulate a more rob

142 xpression, replication, and pathogenicity of Newcastle disease virus (NDV), a green fluorescent prote

143 Newcastle disease virus (NDV), a member of the family Pa

144 Pteropus vampyrus bat kidney (PVK) cells to Newcastle disease virus (NDV), an avian paramyxovirus kn

145 We evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

146 To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

147 We previously engineered Newcastle disease virus (NDV), an avian paramyxovirus, a

148 Newcastle disease virus (NDV), an avian paramyxovirus, i

149 Newcastle disease virus (NDV), an avian paramyxovirus, i

150 Newcastle disease virus (NDV), an avian paramyxovirus, i

151 Newcastle disease virus (NDV), an avian paramyxovirus, i

152 Newcastle disease virus (NDV), an avian paramyxovirus, i

153 the F proteins of SV5 (W3A and WR isolates), Newcastle disease virus (NDV), and human parainfluenza v

154 cular stomatitis virus (VSV), Sindbis virus, Newcastle disease virus (NDV), and Sendai virus (SeV), w

155 of the H5 and H7 hemagglutinin subtypes, and Newcastle disease virus (NDV), are important pathogens i

156 Paramyxoviruses, such as Newcastle disease virus (NDV), assemble in and bud from

157 es such as avian metapneumovirus (aMPV), and Newcastle disease virus (NDV), human pathogens such as h

158 Here we find that intratumoral therapy with Newcastle disease virus (NDV), in addition to the activa

159 yxovirus 1 (APMV-1) RNA, also referred to as Newcastle disease virus (NDV), in clinical samples from

160 When infected with Newcastle Disease Virus (NDV), NOD2 expression in DCs wa

161 For Newcastle disease virus (NDV), one bifunctional site (si

162 Virulent and moderately virulent strains of Newcastle disease virus (NDV), representing avian paramy

163 DCs showed a reduced type I IFN response to Newcastle disease virus (NDV), Sendai virus (SeV), and S

164 For many paramyxoviruses, including Newcastle disease virus (NDV), syncytium formation requi

165 ns (UTRs) in replication and pathogenesis of Newcastle disease virus (NDV), we generated recombinant

166 is hypothesis, L929 cells were infected with Newcastle disease virus (NDV), which led to the inductio

167 Cells infected with a Newcastle disease virus (NDV)-expressing VP35 redistribu

168 Newcastle disease virus (NDV)-induced membrane fusion re

169 Newcastle disease virus (NDV)-induced membrane fusion re

170 e effects of lipopolysaccharide (LPS) on the Newcastle disease virus (NDV)-mediated induction of cyto

171 In this study, we show that Newcastle disease virus (NDV)-vectored H7 (NDV-H7) and N

172 We previously showed that a Newcastle disease virus (NDV)-vectored vaccine expressin

173 e of preexisting immunity in humans, such as Newcastle disease virus (NDV).

174 r IRF phosphorylation in cells infected with Newcastle disease virus (NDV).

175 n impacts in situ vaccination with oncolytic Newcastle Disease Virus (NDV).

176 Newcastle disease virus [NDV (avian paramyxovirus type 1

177 modulate fusion (numbering according to the Newcastle disease virus [NDV] F protein sequence).

178 ession after infection with either Sendai or Newcastle disease viruses or after engagement of the Tol

179 r ordered assembly and release of infectious Newcastle disease virus particles.

180 ion with vectored vaccine, using recombinant Newcastle disease virus (rNDV) expressing glycoprotein D

181 A recombinant Newcastle disease virus (rNDV) expressing simian immunod

182 Recombinant Newcastle disease virus (rNDV) stands out as a vaccine v

183 Recombinant Newcastle disease virus (rNDV) strain LaSota expressing

184 A genetically modified, recombinant form of Newcastle disease virus (rNDV) undergoes ionic strength-

185 Here we developed three recombinant Newcastle disease virus (rNDV) vectored vaccines and ass

186 me this obstacle, we generated a recombinant Newcastle disease virus (rNDV)-vectored experimental nor

187 Using reverse genetics, three recombinant Newcastle disease viruses (rNDVs) were engineered, each

188 ed against CPE resulting from infection with Newcastle disease virus, Sendai virus, canine distemper

189 or Streptococcus, but not Vibrio cholerae or Newcastle disease virus sialidase.

190 Overexpression of Lgp2 inhibits SV and Newcastle disease virus signaling to IFN-stimulated regu

191 We report here that for Newcastle disease virus, the HN receptor avidity is incr

192 rs by about 2.5-fold, and neuraminidase from Newcastle disease virus typically increased infectivity

193 Isolates from the 2002-2003 virulent Newcastle disease virus (v-NDV) outbreak in southern Cal

194 One year after a virulent Newcastle disease virus (vNDV) outbreak in Pakistan, the

195 aramyxovirus 1 (APMV-1; a group encompassing Newcastle disease virus), which is a highly contagious p

196 y this network, we studied DCs infected with Newcastle disease virus, which is able to stimulate inna

197 in primary human dendritic cells infected by Newcastle disease virus, with copy numbers varying from

198 Using recombinant influenza and Newcastle disease viruses, with or without the NS1 gene